US Bancorp
BNTX icon

US Bancorp’s BioNTech BNTX Stock Holding History

US Bancorp’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Sell
1,481
-118
-7% -$11.1K ﹤0.01% 2286
2026
Q1 		$142K Sell
1,599
-104
-6% -$10.7K ﹤0.01% 2188
2025
Q4 		$162K Sell
1,703
-170
-9% -$17.1K ﹤0.01% 2135
2025
Q3 		$185K Sell
1,873
-40
-2% -$4.28K ﹤0.01% 2050
2025
Q2 		$204K Sell
1,913
-342
-15% -$34.5K ﹤0.01% 2008
2025
Q1 		$205K Sell
2,255
-913
-29% -$102K ﹤0.01% 1979
2024
Q4 		$361K Sell
3,168
-1,510
-32% -$172K ﹤0.01% 1683
2024
Q3 		$556K Sell
4,678
-21,012
-82% -$1.93M ﹤0.01% 1459
2024
Q2 		$2.06M Buy
25,690
+1,673
+7% +$153K ﹤0.01% 836
2024
Q1 		$2.22M Sell
24,017
-4,597
-16% -$441K ﹤0.01% 806
2023
Q4 		$3.02M Buy
28,614
+23,119
+421% +$2.33M ﹤0.01% 707
2023
Q3 		$597K Sell
5,495
-191
-3% -$21.1K ﹤0.01% 1287
2023
Q2 		$614K Buy
5,686
+659
+13% +$74.1K ﹤0.01% 1289
2023
Q1 		$626K Buy
5,027
+360
+8% +$49.4K ﹤0.01% 1285
2022
Q4 		$701K Sell
4,667
-361
-7% -$55.6K ﹤0.01% 1229
2022
Q3 		$679K Sell
5,028
-391
-7% -$59.8K ﹤0.01% 1243
2022
Q2 		$808K Buy
5,419
+1,033
+24% +$158K ﹤0.01% 1195
2022
Q1 		$749K Buy
4,386
+332
+8% +$55.8K ﹤0.01% 1317
2021
Q4 		$1.04M Buy
4,054
+1,147
+39% +$314K ﹤0.01% 1181
2021
Q3 		$793K Buy
+2,907
New +$924K ﹤0.01% 1311
2021
Q2 		– Sell
-3
Closed – – 3999
2021
Q1 		$0 Sell
3
-564
-99% -$59.9K ﹤0.01% 3880
2020
Q4 		$46K Buy
+567
New +$55.7K ﹤0.01% 2543

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

US Bancorp's BNTX Position: Q2 2026 in Review

US Bancorp reduced its BioNTech (BNTX) stake by 7.4% in Q2 2026, selling an estimated $11.1K and leaving 1,481 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

US Bancorp first reported a position in BNTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.02M in Q4 2023. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • US Bancorp held 1,481 shares of BioNTech worth $138K as of Q2 2026.
  • US Bancorp sold 118 BioNTech shares in Q2 2026, an estimated $11.1K.
  • BioNTech made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2286 holding.
  • US Bancorp first reported a position in BioNTech in Q4 2020 and has held it in 22 quarters since.
  • US Bancorp's BioNTech position peaked at $3.02M in Q4 2023.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.